Development Level

Tbio 7 | 11,445
Tchem 4 | 1,598

IMPC Phenotype

abnormal coat appearance 1 | 31
decreased circulating glucose ... 1 | 126
preweaning lethality, incomple... 1 | 499
short tibia 1 | 97

Disease

Carcinoma 8 | 11,493
ovarian cancer 7 | 8,520
Cancer 6 | 2,499
Mucopolysaccharidosis 5 | 26
glioblastoma 5 | 5,792
Autosomal recessive predisposition 4 | 1,442
group 3 medulloblastoma 4 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,291
lung adenocarcinoma 4 | 2,716
lung cancer 4 | 4,740
osteosarcoma 4 | 7,950
psoriasis 4 | 6,694
Breast cancer 3 | 3,578
Multiple myeloma 3 | 1,332
Neurodegenerative disease 3 | 414
esophageal adenocarcinoma 3 | 737
interstitial cystitis 3 | 2,312
medulloblastoma, large-cell 3 | 6,241
non-small cell lung cancer 3 | 2,890
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
Atopic dermatitis 2 | 952
Big calvaria 2 | 147
Blind Vision 2 | 111
Blindness, Legal 2 | 110
Cherry red spot of the macula 2 | 7
Coarse facial features 2 | 108
Duchenne muscular dystrophy 2 | 601
Dysarthria 2 | 192
Gangliosidosis 2 | 20
Increased head circumference 2 | 147
Increased size of cranium 2 | 147
Increased size of skull 2 | 147
Intellectual disability 2 | 1,016
Kidney cancer 2 | 2,613
Lymphedema 2 | 42
Muscle hypotonia 2 | 571
Short stature 2 | 531
Thickened facial skin with coarse facial features 2 | 108
Waldenstrons macroglobulinemia 2 | 765
adrenocortical carcinoma 2 | 1,428
astrocytoma 2 | 1,146
atypical teratoid / rhabdoid tumor 2 | 5,112
breast carcinoma 2 | 1,638
colon cancer 2 | 1,478
dermatomyositis 2 | 966
diabetes mellitus 2 | 1,728
ductal carcinoma in situ 2 | 1,745
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
invasive ductal carcinoma 2 | 2,951
juvenile dermatomyositis 2 | 1,187
mucosa-associated lymphoid tissue lymphoma 2 | 484
pancreatic cancer 2 | 2,398
primitive neuroectodermal tumor 2 | 3,035
ulcerative colitis 2 | 1,819
Abdominal pain, episodic 1 | 9
Actual Aspiration 1 | 8
Apathy 1 | 16
Ascites 1 | 22
Ataxia, Appendicular 1 | 25
Barrett Esophagus 1 | 16
Brucellosis 1 | 24
Cardiomyopathy, Hypertrophic 1 | 24
Cerebellar Dysmetria 1 | 56
Congenital pectus carinatum 1 | 52
Crimean-Congo hemorrhagic fever 1 | 9
Dirofilariasis 1 | 3
Dysdiadochokinesis 1 | 25
Edema 1 | 81
Erectile dysfunction 1 | 32
Exaggerated acoustic startle response 1 | 8
Exaggerated startle response 1 | 8
Familial cancer of breast 1 | 12
Gm2-ganglioside accumulation 1 | 2
Hepatitis 1 | 67
Hydrops Fetalis 1 | 21
Hyperexplexia 1 | 8
Increased startle response 1 | 8
La Crosse encephalitis 1 | 5
Louping ill 1 | 3
Lyme disease 1 | 26
Lymphatic obstruction 1 | 21
Metatarsus Varus 1 | 24
Murray Valley encephalitis 1 | 3
Non-immune hydrops fetalis 1 | 11
ODONTOID HYPOPLASIA 1 | 16
Onset of lymphedema around puberty 1 | 21
Pain 1 | 103
Pasteurellosis 1 | 12
Periodontal disease 1 | 40
Platyspondyly 1 | 56
Poor head control 1 | 14
Pulmonary aspiration 1 | 8
Sandhoff disease 1 | 3
Skin Abnormalities 1 | 37
Tay-Sachs disease 1 | 6
Toeing-in 1 | 24
Tularemia 1 | 23
West Nile fever 1 | 7
intermittent abdominal pain 1 | 9

Tissue

Blood and immune system 11 | 16,909
Cardiovascular System 11 | 15,192
Digestive Tract 11 | 17,369
Endocrine System 11 | 18,159
Female tissues 11 | 17,400
Liver and Pancreas 11 | 16,750
Male tissues 11 | 17,142
Nervous System 11 | 16,725
Respiratory system 11 | 16,393
Skin and soft tissues 11 | 17,230
Urinary Tract 11 | 16,678

Target Family

Enzyme 6 | 4,145
Non-IDG 4 | 12,091
Transporter 1 | 473

Reactome Pathway

Hyaluronan uptake and degradat... 11 | 11
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Calcineurin B homologous protein 1 CHP1 Tbio Non-IDG -1.63966 41.9 162
Sodium/hydrogen exchanger 1 SLC9A1 Tchem Transporter -2.93178 921.2 198
Hyaluronidase-2 HYAL2 Tbio Enzyme -2.01424 105.1 212
Hyaluronidase-1 HYAL1 Tbio Enzyme -1.88328 77.3 220
Stabilin-2 STAB2 Tbio Non-IDG -2.81864 640.7 72
Lymphatic vessel endothelial hyaluronic acid receptor 1 LYVE1 Tbio Non-IDG -2.77184 557.5 586
Hyaluronidase-3 HYAL3 Tbio Enzyme -0.92743 7.88 126
Beta-hexosaminidase subunit alpha HEXA Tchem Enzyme -2.83300 675.5 327
Hyaluronan mediated motility receptor HMMR Tbio Non-IDG -2.26618 208.1 306
Beta-glucuronidase GUSB Tchem Enzyme -3.12070 1155.3 291